Blinatumomab/MethotrexateGrade3/4 neurotoxicity and lack of efficacy: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2027卷 / 1期

关键词：

D O I：

10.1007/s40278-024-67287-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：98 / 98

相关论文

共 50 条

[1] Blinatumomab/immunosuppressantsVarious toxicities and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1889 (1) : 91 - 91
[2] Axicabtagene-ciloleucelGrade 2 neurotoxicity and lack of efficacy : 3 case reports
Reactions Weekly, 2024, 2019 (1) : 74 - 74
[3] Multiple drugsSeizure, neurotoxicity and lack of efficacy: 3 case reports
Reactions Weekly, 2022, 1924 (1) : 333 - 333
[4] Multiple drugsMyelotoxicity, neurotoxicity and lack of efficacy: 3 case reports
Reactions Weekly, 2020, 1819 (1) : 191 - 191
[5] Blinatumomab/dasatinibTransient transaminase elevation and neurotoxicity: 2 case reports
Reactions Weekly, 2020, 1787 (1) : 111 - 111
[6] Multiple drugsLeptomeningeal calcium deposition, neurotoxicity and lack of efficacy: 3 case reports
Reactions Weekly, 2022, 1911 (1) : 307 - 307
[7] AntineoplasticsLack of efficacy and neurotoxicity: 2 case reports
Reactions Weekly, 2025, 2048 (1) : 38 - 38
[8] GanciclovirNeutropenia and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1935 (1) : 208 - 208
[9] WarfarinNosebleed and lack of efficacy: 4 case reports
Reactions Weekly, 2021, 1878 (1) : 512 - 512
[10] EverolimusHyperlipidaemia and lack of efficacy: 4 case reports
Reactions Weekly, 2023, 1971 (1) : 117 - 117

← 1 2 3 4 5 →